Euclia Private Capital Company is one of the very first spin-off companies of NTUA. Its establishment was approved by the Senate of NTUA on September 23, 2021.
EUCLIA was founded by researchers of the School of Chemical Engineering with strong expertise in the fields of chemoinformatics, nanoinformatics and bioinformatics.
Euclia’s vision is to promote health, safety & sustainability by developing & democratizing AI solutions, discovering novel drugs and designing next-gen materials.
Explore more about Euclia:
https://www.euclia.io/